麻豆传媒

Three-day intervention boosted time spent in normal glucose range

But significant weight loss reported for both

Relationship was mediated by comorbid dyslipidemia

Saxenda group six times more likely to lose at least 5% of BMI

But higher severe hypoglycemia risk with efsitora in type 1 diabetes likely precludes its use

Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk

The faster formulation led to fewer hypoglycemia events versus conventional insulin aspart

However, no FDA-approved systems have a pregnancy indication yet

EMERGE trial misses on primary endpoint, but secondary outcomes suggest potential benefit

Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro

Data support looking at enterovirus vaccination for prevention

Systematic review indicates vast sex differences in youth with type 1 diabetes

Other groups at risk for early mortality include smokers, those diagnosed at younger ages

Preservation of ovaries played into this association